Wei-ru Chiou

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Impact of venous thromboembolism on mortality in hospitalized patients with inflammatory bowel disease: analysis of the MIMIC-IV database, 2008 to 2022.

Impact of venous thromboembolism on mortality in hospitalized patients with inflammatory bowel disease: analysis of the MIMIC-IV database, 2008 to 2022.

Journal: BMC gastroenterology

Published: July 11, 2025

Systemic immune-inflammation index in critically ill patients with renal failure: a retrospective cohort study from Medical Information Mart for Intensive Care IV (MIMIC-IV) database.

Systemic immune-inflammation index in critically ill patients with renal failure: a retrospective cohort study from Medical Information Mart for Intensive Care IV (MIMIC-IV) database.

Journal: BMJ open

Published: June 12, 2025

Tolerability for older, persistence for younger: a real-world evidence on sacubitril/valsartan in an Asian heart failure cohort across age.

Tolerability for older, persistence for younger: a real-world evidence on sacubitril/valsartan in an Asian heart failure cohort across age.

Journal: Frontiers in cardiovascular medicine

Published: April 29, 2025

Efficacy in predicting mortality of patients with heart failure using heart rate before intensive care unit discharge: a retrospective cohort study from MIMIC-IV Database.

Efficacy in predicting mortality of patients with heart failure using heart rate before intensive care unit discharge: a retrospective cohort study from MIMIC-IV Database.

Journal: BMJ open

Published: December 26, 2024

Efficiency and safety of a guidewire-less approach to superselective transarterial microcatheter procedures in hepatic cancer interventions.

Efficiency and safety of a guidewire-less approach to superselective transarterial microcatheter procedures in hepatic cancer interventions.

Journal: BMC cancer

Published: August 26, 2024

Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation.

Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation.

Journal: Journal of clinical medicine

Published: September 20, 2023

Multicenter Experience of Percutaneous Left Atrial Appendage Occlusion in Current Indications and Different Anesthetic Approaches.

Multicenter Experience of Percutaneous Left Atrial Appendage Occlusion in Current Indications and Different Anesthetic Approaches.

Journal: Acta Cardiologica Sinica

Published: September 14, 2023

Author Correction: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation.

Author Correction: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation.

Journal: Scientific reports

Published: March 09, 2023

Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan.

Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: June 17, 2022

Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartan.

Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartan.

Journal: Frontiers in cardiovascular medicine

Published: May 22, 2022

Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy.

Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy.

Journal: ESC heart failure

Published: January 09, 2022

Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patients With Non-Permanent Atrial Fibrillation: A Retrospective Cohort Study.

Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patients With Non-Permanent Atrial Fibrillation: A Retrospective Cohort Study.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: December 13, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026